EYPT Stock On Track To Hit 16-Month Lows After Wet AMD Trial Setback – Retail Sees Ocular Therapeutics As A Better Buyout Candidate
EYPT Stock On Track To Hit 16-Month Lows After Wet AMD Trial Setback – Retail Sees Ocular Therapeutics As A Better Buyout Candidate tradingview.com
Covered in this story
What has happened since
- Eyepoint Inc is down 91.2% since this was published, 66 days ago.
- Advanced Micro Devices is up 0.4% since this was published, 66 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $EYPT yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Eyepoint Inc →Summary aggregated from tradingview.com's public RSS feed. The full reporting belongs to tradingview.com — please read it on their site.